Explore

Companies
Investors
Funds
Markets
Compare

Capbase

About
FAQ
Data & sources
Contribute
API

Compare

Crunchbase alternative
PitchBook alternative

Legal

Terms of Service
Privacy Policy
Takedown policy

VERSATOPE THERAPEUTICS, INC. — Funding, Investors & Profile — Capbase

← All companies

Compare History

VERSATOPE THERAPEUTICS, INC.

Private

Won 6 federal SBIR/STTR research awards from HHS and other federal agencies.

Department of Health and Human ServicesNational Institutes of Health

SAM UEI: VSMPM3EGYYA6

Founded: —Source: [GOV]
Headquarters: LOWELL, MassachusettsSource: [GOV]
Country: United StatesSource: [GOV]
Headcount: 14Source: [GOV]
Stage

$0Source: [GOV]Total raised

UndisclosedSource: [GOV]Last valuation

Overview

VERSATOPE THERAPEUTICS, INC. has been awarded 6 US Small Business Innovation Research (SBIR/STTR) contracts totalling $3,424,657 between 2018 and 2023. These are non-dilutive federal research grants, not equity financing. The company is based in LOWELL, Massachusetts.

Funding rounds

6 rounds

6 rounds · latest SBIR Phase II award (HHS), Dec 2023

Investors

No investors recorded yet for VERSATOPE THERAPEUTICS, INC..

Add an investor

People

Leadership

CHRISTOPHER LOCHERPrincipal investigatorSince 2024Source: [GOV]

Ly PhanPrincipal investigatorSince 2018Source: [GOV]

Acquisitions

VERSATOPE THERAPEUTICS, INC. has no recorded acquisitions.

Add an acquisition

Exits

Still private — no exit on record.

Record an exit

Diversity investments

No diversity signals recorded yet for VERSATOPE THERAPEUTICS, INC..

Add diversity data

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.

Seed

Sector

Healthcare